Skip to main
XRAY

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

DENTSPLY SIRONA (XRAY) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 8%
Hold 58%
Sell 8%
Strong Sell 8%

Bulls say

Dentsply Sirona is showing signs of improvement and progress in its fourth quarter results, with strong top-line and adjusted EPS. The company's performance in the U.S. region has shown positive trends in key areas, and the recent restructuring plan and leadership changes demonstrate a commitment to future growth and success. Furthermore, the decision to eliminate the dividend in order to reduce debt and repurchase shares appears to be a smart move. With a strong financial outlook for 2026 and potential for continued operational progress, the company has a positive outlook for future growth.

Bears say

Dentsply Sirona is struggling operationally and has recently experienced significant executive turnover, including the departure of their CFO. While there is potential for the dental market to stabilize and for the company's various initiatives to improve performance, there is no evidence of this yet and their profitability outlook for FY/26 has been reduced. Additionally, their recent history of management changes and failed turnaround plans adds risk to the investment. Despite trading at bargain basement levels, investing in Dentsply Sirona requires patience and a longer-term mindset. If the new leadership can successfully turn the company around, there is potential for significant upside to the stock price.

DENTSPLY SIRONA (XRAY) has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 8% recommend Buy, 58% suggest Holding, 8% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of DENTSPLY SIRONA and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DENTSPLY SIRONA (XRAY) Forecast

Analysts have given DENTSPLY SIRONA (XRAY) a Hold based on their latest research and market trends.

According to 12 analysts, DENTSPLY SIRONA (XRAY) has a Hold consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DENTSPLY SIRONA (XRAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.